Search
Alanine
go.drugbank.com/drugs/DB00160ApprovedInvestigationalNutraceuticalIt is involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and the central nervous system. … Alanine is a non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination.
Mixtures: AMINOSTERIL N-HEPA FOR INTRAVENOUS INFUSION 8%, OLICLINOMEL N7-1000 EMULSION FOR INFUSIONKeratoconjunctivitis Sicca (KCS)
go.drugbank.com/conditions/DBCOND0105777Drugs: Hydroxypropyl celluloseSynonyms: Keratoconjunctivitis sicca, in Sjögren syndrome, Keratoconjunctivitis sicca, in Sjogren's syndromeThiocolchicoside
go.drugbank.com/drugs/DB11582InvestigationalIt is a muscle relaxant with anti-inflammatory and analgesic effects. It has potent convulsant activity and should not be administered to individuals prone to seizures.[L1663] … Thiocolchicoside is a semi-synthetic derivative of the colchicine, a natural anti-inflammatory glycoside which originates from the flower seeds of _Superba gloriosa_.
Mixtures: TIYOKAS 25MG/4MG SAŞE, 20 SAŞE, TIYOKAS 25MG/8MG SAŞE, 14 SAŞEProducts: THIOSPA 4 MG /2 ML IM ENJEKSİYONLUK ÇÖZELTİ İÇEREN AMPUL, 2 ML X 6 AMPUL, MYAL FORT 8 MG KAPSUL, 10 ADETAfoxolaner
go.drugbank.com/drugs/DB11369ExperimentalVet approvedMixtures: Nexgard Spectra 38mg/8mg Chewable Tablets for Dogs >7.5-15kg, Nexgard Spectra 9mg/2mg Chewable Tablets for Dogs 2-3.5kgProducts: NexGard 11mg chewable tablets for dogs 2-4kg, NexGard 136mg chewable tablets for dogs > 25-50kgPyridostigmine
go.drugbank.com/drugs/DB00545ApprovedInvestigational[L32408, L32413] In addition to treating myasthenia gravis, pyridostigmine is used to reverse neuromuscular blocks, relieve symptoms in congenital myasthenic syndromes, and protect against certain nerve … Myasthenia gravis is an autoimmune disease involving dysfunction at the neuromuscular junction, most commonly due to autoantibodies directed against the acetylcholine receptor (AChR), which results in
International brands: Kalymin NProducts: Regonol Inj 5mg/mlLimaprost
go.drugbank.com/drugs/DB09211InvestigationalIn 2011, Ono and DSP initiated Phase II clinical trials in Japan for the treatment of carpal tunnel syndrome. In 2013, these trials were discontinued because the study failed to demonstrate efficacy. … Ono and DSP also discontinued the development of limaprost alfadex for the additional indication of cervical spondylosis in 2008 due to the failure to demonstrate the anticipated efficacy in a Phase II
Products: OPALMON TABLETS 5 ugBisoprolol
go.drugbank.com/drugs/DB00612ApprovedInvestigational[A180472,L7219] It is considered a potent drug with a long-half life that can be used once daily to reduce the need for multiple doses of antihypertensive drugs. … It may be used alone or in combination with other drugs to manage hypertension[L7219] and can be useful in patients with chronic obstructive pulmonary disease (COPD) due to its receptor selectivity.
Categories: Antihypertensive Agents Indicated for HypertensionSynonyms: (RS)-1-(4-(2-Isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanolSoybean oil
go.drugbank.com/drugs/DB09422ApprovedInvestigationalIt is used as a cooking oil and lipid emulsion for parenteral nutrition in clinical settings. Soybean oil-based lipid emulsion is the only FDA-approved lipid formulation for clinical use. … It is a complex mixture of triglycerides where per 100 g, soybean oil has 16 g of saturated fat, 23 g of monounsaturated fat, and 58 g of polyunsaturated fat.
Mixtures: LIPOFUNDIN N EMULSION FOR INFUSION 20 %, No name providedProducts: LIPOFUNDIN 20 %N, LIPOFUNDIN 10 %NAcetylcysteine zinc
go.drugbank.com/drugs/DB14479InvestigationalSynonyms: N-acetyl-L-cysteine zinc saltCategories: Compounds used in a research, industrial, or household settingItraconazole
go.drugbank.com/drugs/DB01167ApprovedInvestigational[A34257] It is a 1:1:1:1 racemic mixture of four diastereomers, made up of two enantiomeric pairs, each possessing three chiral centers. … [L50051] Itraconazole was first approved in the US in 1992 [L50056] and is available orally.
Categories: Antimycotics for Systemic Use, Antiinfectives for Systemic UseProducts: SPORANOX® IV, Z-FIN